| scholarly article | Q13442814 |
| P2093 | author name string | Walter H Watson | |
| Jacqueline M Heilman | |||
| Jeanine C Spielberger | |||
| Laura L Hughes | |||
| P2860 | cites work | Arsenic induces oxidant stress and NF-KB activation in cultured aortic endothelial cells | Q23909531 |
| Thioredoxin reductase | Q24531944 | ||
| Characterization of alternative cytosolic forms and cellular targets of mouse mitochondrial thioredoxin reductase | Q28570489 | ||
| Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene | Q29409898 | ||
| Physiological functions of thioredoxin and thioredoxin reductase | Q29615600 | ||
| Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif | Q30950439 | ||
| Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide | Q33291299 | ||
| Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication | Q33304452 | ||
| Inactivation of thioredoxin reductases reveals a complex interplay between thioredoxin and glutathione pathways in Arabidopsis development | Q33344187 | ||
| Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes | Q33938954 | ||
| Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity | Q34416920 | ||
| Thioredoxin and related molecules--from biology to health and disease | Q34583038 | ||
| Study of interactions between arsenicals and thioredoxins (human and E. coli) using mass spectrometry | Q34701428 | ||
| Thioredoxin signaling as a target for cancer therapy | Q36870409 | ||
| Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy | Q37018020 | ||
| Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. | Q40049658 | ||
| Oxidation of nuclear thioredoxin during oxidative stress | Q40647018 | ||
| Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling | Q42156579 | ||
| Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds | Q42540715 | ||
| Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase | Q43592091 | ||
| Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells | Q44217769 | ||
| Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. | Q44999323 | ||
| Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. | Q46638828 | ||
| Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions | Q46842814 | ||
| Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy | Q46889314 | ||
| Spectroscopic characterization of thioredoxin covalently modified with monofunctional organoarsenical reagents. | Q54767373 | ||
| ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOTIDES.V. PURIFICATION AND PROPERTIES OF THIOREDOXIN REDUCTASE FROM ESCHERICHIA COLI B | Q55037601 | ||
| Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase | Q73091945 | ||
| Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue | Q74473300 | ||
| Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities | Q78171744 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 832-836 | |
| P577 | publication date | 2008-02-11 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation | |
| P478 | volume | 368 |
| Q37133504 | Acrolein-induced activation of mitogen-activated protein kinase signaling is mediated by alkylation of thioredoxin reductase and thioredoxin 1 |
| Q34931100 | Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology |
| Q34619261 | Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms |
| Q34049230 | Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells |
| Q33326607 | Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells |
| Q37250664 | Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin |
| Q34221890 | Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth |
| Q35877978 | DIO2 modifies inflammatory responses in chondrocytes |
| Q36916338 | EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells |
| Q27317372 | Generation of Double-Labeled Reporter Cell Lines for Studying Co-Dynamics of Endogenous Proteins in Individual Human Cells |
| Q39278850 | Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose |
| Q33951227 | Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration |
| Q37101209 | Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo |
| Q33526346 | JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1 |
| Q41884316 | Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. |
| Q37367544 | No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue |
| Q39391432 | Protection of CDC25 phosphatases against oxidative stress in breast cancer cells: evaluation of the implication of the thioredoxin system |
| Q36844094 | Redox activation of Fe(III)-thiosemicarbazones and Fe(III)-bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping |
| Q28649897 | Redox theory of aging |
| Q34107312 | Respiration-dependent H2O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system |
| Q28397704 | The effects of chromium(VI) on the thioredoxin system: implications for redox regulation |
| Q37399751 | The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells |
| Q24626002 | The human selenoproteome: recent insights into functions and regulation |
| Q33967269 | The selenium-independent inherent pro-oxidant NADPH oxidase activity of mammalian thioredoxin reductase and its selenium-dependent direct peroxidase activities |
| Q35069234 | Thiol/disulfide redox states in signaling and sensing |
| Q39316517 | Thiophosphate and selenite conversely modulate cell death induced by glutathione depletion or cisplatin: effects related to activity and Sec contents of thioredoxin reductase. |
| Q39648281 | Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction |
| Q39502076 | Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity |
| Q28080723 | TrxR1 as a potent regulator of the Nrf2-Keap1 response system |
Search more.